Taking the results of Wen et al. and Sun et al. together, it appears that EZH2 promotes EMT in NSCLC cells by inhibiting the lncRNA SPRY-IT1, inducing invasion, metastasis, and proliferation. Here, EZH2 is linked to non-small cell lung carcinoma.